PharVision Advisers LLC Makes New $251,000 Investment in Option Care Health, Inc. (NASDAQ:OPCH)

PharVision Advisers LLC acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 10,807 shares of the company's stock, valued at approximately $251,000.

Other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Option Care Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock valued at $448,118,000 after buying an additional 75,313 shares in the last quarter. Wellington Management Group LLP lifted its stake in Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after purchasing an additional 8,400,208 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Option Care Health by 17.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after purchasing an additional 591,042 shares during the last quarter. Northern Trust Corp grew its position in shares of Option Care Health by 11.8% during the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock valued at $60,934,000 after purchasing an additional 278,158 shares in the last quarter. Finally, Norges Bank bought a new stake in Option Care Health in the fourth quarter worth $60,219,000. 98.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on OPCH. Barrington Research reissued an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 30th. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Trading Down 0.4%

NASDAQ OPCH traded down $0.12 on Wednesday, reaching $32.00. The company had a trading volume of 219,528 shares, compared to its average volume of 1,852,313. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The business has a 50 day moving average of $32.89 and a two-hundred day moving average of $29.47. The firm has a market cap of $5.24 billion, a price-to-earnings ratio of 26.89, a P/E/G ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company's quarterly revenue was up 16.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.26 earnings per share. Analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Transactions at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.64% of the company's stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.